EP0285646A4 - Apport intracellulaire de produits d'expression. - Google Patents

Apport intracellulaire de produits d'expression.

Info

Publication number
EP0285646A4
EP0285646A4 EP19870906870 EP87906870A EP0285646A4 EP 0285646 A4 EP0285646 A4 EP 0285646A4 EP 19870906870 EP19870906870 EP 19870906870 EP 87906870 A EP87906870 A EP 87906870A EP 0285646 A4 EP0285646 A4 EP 0285646A4
Authority
EP
European Patent Office
Prior art keywords
gene
region
peptide
sequence
transit peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870906870
Other languages
German (de)
English (en)
Other versions
EP0285646A1 (fr
Inventor
Luca Comai
David M Stalker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Calgene LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calgene LLC filed Critical Calgene LLC
Publication of EP0285646A1 publication Critical patent/EP0285646A1/fr
Publication of EP0285646A4 publication Critical patent/EP0285646A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8221—Transit peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/08—Fusion polypeptide containing a localisation/targetting motif containing a chloroplast localisation signal

Definitions

  • This invention relates to techniques for directing the transport of proteinaceous gene products to particular organelles of a cell in which the product is being produced.
  • Plant cells contain distinct subcellular compartments delimited by membranes.
  • the most conspicuous organelles are the chloroplasts.
  • the chloroplast present in leaf cells is one developmental stage of this organelle.
  • Proplastids, etioplasts, amyloplasts, and chromoplasts are different stages.
  • the embodiments of this invention apply to the organelle "at large,” which will be referred to as "chloroplast.”
  • the majority of chloroplast proteins are coded by nuclear genes synthesized in the cytoplasm and then imported into the chloroplasts. Import is associated with the removal of an amino terminal portion, the transit peptide.
  • the transit peptide is linked to the mature peptide by an amino acid sequence, normally requiring at least two amino acids, which is recognized by a specific protease associated with the chloroplast.
  • the proforra of the mature peptide is translocated to the chloroplast and processed as a result of recognition by one or more proteins.
  • Van den Broeck et al., Nature (1985) 313: 358-363 describes the use of the transit peptide of the pea small subunit ribulose-1,5-bisphosphate carboxylase joined to the NPT-II gene to provide a chimeric gene which is shown to be capable of translocation in a plant host.
  • Lubben and Keegstra, Proc. Natl. Acad. Scl. USA (1986) 83:5502-5506 report the use of the soybean SSU transit peptide plus 13 amino acids of the pea SSU mature protein plus a heat shock protein for translocation to chloroplasts. See also the references cited therein as well as Cashmore et al., Biotechnology (1985) 803-808, and Karlin-Neumann et al., EMB0 J.
  • DNA constructs and the resulting proteinaceous products expressed from such constructs are provided resulting In the translocation of proteins expressed in the cytoplasm into chloroplasts.
  • the constructs involve sequences encoding a transit peptide recognized by the host plant cell for transporting a cytoplasmic expressed protein to the chloroplast, a short polar or hydrophilic region having at least two positively charged amino acids, and a protein of interest which is fused to the short polar region.
  • the polar region may be naturally occurring or synthetic, and serves to provide for efficient transport from the cytoplasm to the chloroplast, usually with efficient processing and removal of the transit. peptide.
  • the gene constructs involve in the direction of transcription of the sense or positive polarity strand, a transcriptional initiation region recognized by the plant host, a translated region, comprising the gene of interest, and a transcriptional termination region recognized by the plant host cell.
  • the translated region comprises a transit peptide recognized by the host for transporting a polypeptide from the cytoplasm into the chloroplast, usually a processing signal which may be the same or different from the processing signal naturally associated with the transit peptide for cleaving the transit peptide upon transport into the chloroplast, a sequence encoding a polar amino acid region having at least two amino acids having positive charges, and the gene of interest, where the transit peptide, processing sequence, polar region sequence, and gene of interest are all in proper reading frame.
  • a significant number of biological processes are involved in the chloroplast. Therefore, there is substantial interest in having a wide variety of proteins introduced into the chloroplast, where the proteins may result in modification of a biological process, imparting new capabilities to the chloroplast, or protecting a biological process from interference.
  • the chloroplast is the site for production of fatty acids, by introducing various proteins into the chloroplast, one may enhance the production of fatty acids, modify the size distribution of fatty acids or modify the unsaturated character of the fatty acids, both as to number and site.
  • Various enzymes which may be involved in such a function include acyl carrier protein (ACP), acetyl-CoA ACP transacylase, thioesterase, malonyl-CoA ACP transacylase, 8-ketoacyl ACP, synthetase, etc.
  • proteins which are produced in the cytoplasm and translocated to the chloroplast include the small subunit of the ribulose-1,5-bisphosphate carboxylase, chlorophyll A and B binding protein, ferredoxin, enzymes of the shikimic acid pathway, as well as other amino acid biosynthetic enzymes.
  • the biological process for the synthesis of aromatic amino acids which includes in the pathway the enzyme 5-enolpyruvyl-3phosphoshikimate synthetase. This enzyme is of particular interest because it is the target for a commonly used herbicide glyphosate.
  • the expression product is a precursor or proform of the desired peptide, having a leader sequence recognized by the host for translocation from the cytoplasm joined to the gene of interest by a peptide sequence recognized as a processing signal.
  • the proform of the peptide produced in the cytoplasm is translocated to the chloroplast, where it is processed by cleavage of a peptide.
  • the processing signal DNA sequence encodes an oligopeptide recognized by a peptidase.
  • the expression product cleaved by the peptidase to fulfill its intended function as a mature protein.
  • Any gene of interest may be joined to a transit peptide encoding sequence and processing signal through a linking sequence encoding a polar region.
  • Any of the genes encoding the proteins indicated above may be employed. As indicated, these genes may be involved in modifying the composition of a natural composition, providing protection from stress, e.g., herbicides, enhancing a particular function or the like.
  • the aroA gene is involved in expression of enzymes in the shikimic acid metabolic pathway, particularly the enzyme that catalyzes the conversion of phosphoenolpyruvate and 5-phosphoshikiraIc acid to
  • 5-enolpyruvyl-3-phosphoshikimic acid The enzyme is 5-enolpyruvyl-3-phosphoshikimate synthetase (EC:2.5.1.19); referred to hereafter as ES-3-P synthetase.
  • the natural gene product is useful in enhancing the production of shikimic acid in metabolic pathway products.
  • Genes that express an enzyme which is resistant to glyphosate (N-phosophonomethyl glycine), an important and commonly used herbicide, are useful in imparting glyphosate resistance to a normally glyphosate-sensitive cell in which the structural gene is expressed.
  • U.S. Patent No. 4,535,060 describes such a mutated structural gene.
  • the transit peptide and processing signal may be derived from any plant protein which is expressed in the cytoplasm and translocated to the chloroplast.
  • the amino acid sequence absent from the mature protein and coded for by the messenger beginning at the initiation codon, usually a methionine will normally be the transit sequence.
  • Exemplary of transit sequences is the transit peptide of the small subunit (SSU) of the ribulose-1,5-bisphosphate carboxylase and that from acyl carrier protein (ACP), Fragments from the natural transit sequence that retain their transport activity can also be used.
  • SSU small subunit
  • ACP acyl carrier protein
  • the transit peptide is a sequence capable of translocating a peptide Joined to the transit peptide to the chloroplast and may be the whole wild-type transit peptide, a functional fragment therof, or a functional mutant thereof. The full natural sequence is naturally also included. For the most part, the transit peptides from one plant are generally recognized by other plants. Thus, the transit peptide may be native to or heterologous to the ultimate host in which the chimeric gene is introduced. Transit peptides may come from soybean, corn, petunias, tobacco, brasstea, tomato, wheat, pea, etc. The transit peptide will usually have at least about 20 amino acids and not more than about 100 amino acids.
  • the translated region will provide for a chimeric gene having three components: (1) the transit peptide and normally the processing signal, which provides for translocation of the expression product from the cytoplasm to the chloroplast and processing for removal of the transit peptide; (2) a polar region which affects the efficiency of the translocation and stability of the gene of interest; and (3) the gene of interest which provides for a functional protein product which will provide a change in the functioning of the chloroplast.
  • the polar region which will separate the transit peptide and processing signal from the gene of interest will normally involve at least 6, usually 8, codons and not more than about 20 codons, although there may be specific exceptions.
  • the polar region may be the naturally occurring region of the mature peptide naturally joined to the transit peptide, may be a region obtained from a different protein naturally associated with a transit peptide and providing the N- terminus of such mature protein, or may be a synthetic sequence encoding an unnatural polypeptide sequence. Besides the number of codons, the sequence will be further characterized by being hydrophilic and desirably having at least about 40 number percent, preferably at least about 50 number percent of the polar amincj acids.
  • the polar amino acids comprise the charged and neutral amino acids having a heteroatom in the chain. These amino acids include the charged amino acids, lysine (K), arginine (R), aspartic acid (D), glutamic acid (E), and histidine (H) and the neutral polar amino acids serine (S), threonine (T), asparagine (N), glutamine (Q).
  • the sequence will include at least two positively charged amino acids, preferably at least three, and may include up to five positively charged amino acids, but usually not more than 25 number percent, preferably not more than 20 number percent of the sequence will be positively charged amino acids. Charged amino acids will be present in the range from 6 to 15 amino acids and may also be present as the first amino acid after the processing signal.
  • the polar region may be from 12 to 30 amino acids of the N-terminus of the mature acp.
  • hydrophilic region the hydrophilic or hydrophobic character of a protein region may be determined as described by Kyte and Doolittle, J. mol. Bio. (1982) 157:105-132. This reference indicates the exposed nature of the region.
  • the N-terminal region of the plant acyl carrier protein may be employed, with up to and including 35 codons, preferably not more than about 30 codons and may range from about 12 codons to 30 codons.
  • the polar region will be designed to usually be followed by a hydrophobic region, which will have at least about 50% hydrophobic amino acids, preferably at least about 60% hydrophobic amino acids in the amino acids immediately following the last positively charged amino acid.
  • the particular hydrophobic amino acids include glycine (G), alanine (A), proline (P), and more particularly leucine (L), isoleucine (I), valine (V), and the aromatic amino acids phenylalanine (F), tyrosine (Y), and tryptophan (W).
  • the next five amino acids, more desirably the next ten amino acids following the last positively charged amino acid of the polar region will be free of positively charged amino acids.
  • This hydrophobic region can be achieved by employing the polar region, having naturally present the appropriate amino acids as part of the gene of interest, the wild-type sequence associated with the transit peptide, synthetic sequences or combinations thereof.
  • the polar region may have an effect on the gene of interest, as to its stability, activity, location in the chloroplast, or other characteristic. Therefore, for the most part, the polar region will be selected, so as to minimize the adverse effect on the role of the gene of Interest In the chloroplast.
  • various strategies may be employed for synthesizing the chimeric gene. Where the naturally occurring N- terminal codons of the mature protein normally associated with the transit peptide are employed, the gene of interest will be joined to the polar region in the appropriate reading frame.
  • the transit peptide containing gene may be cleaved at that site and manipulated for joining to the gene of interest.
  • an alternative restriction site may be employed and an adapter used to restore the lost codons.
  • resection may be employed with Bal31 to provide for a blunt terminus which may be joined to a blunt ended gene of interest.
  • the polar region is not naturally joined to the transit peptide, it may by synthesized or obtained from any convenient source and be used as an adapter or bridge to link the transit peptide to the gene of interest. In the absence of convenient restriction sites in the transit peptide and processing signal portion and/or the gene of interest, the polar region may serve as an adapter restoring any codons lost by restricting internal to the other regions.
  • the DNA sequence encoding the transit peptide may be the complete transit-peptide-encoding sequence including the processing signal or a truncated transitpeptide-encoding sequence lacking from about 1 to 10 codons or a portion of a codon from the 3'-terminus.
  • one or more changes may be made in the nature of mutations, deletions or insertions in the transit peptide and processing signal, where such change may provide for convenience in construction, providing for a convenient restriction site or removing an. inconvenient restriction site.
  • the mutations may be conservative or non-conservative, so that the transit peptide may be the same or different from the wild-type transit peptide.
  • the individual sequences may be obtained from naturally occuring sources, may be sequences modified from naturally occurring sources, may be combinations of sequences from naturally occurring and synthetic sequences, and the like.
  • Various techniques can be used for modifying these sequences such as in vitro mutagenesis, primer repair, resection, ligation, tailing, etc.
  • the various techniques may be carried out in accordance with conventional procedures.
  • the structural genes of interest may be derived from cDNA, from chromosomal DNA or may be synthesized in whole or in part.
  • All or a portion of the structural gene may be a naturally occurring sequence coding for a wild-type peptide or a synthetic sequence in whole or in part coding for a wild-type peptide or a mutant, as a result of a point mutation, insertions or deletions. In some situations it may be desirable to modify all or a portion of the codons, for example to enhance expression employing host-preferred codons.
  • heterologous genes from other than plant sources, such as microorganisms, e.g. bacteria and fungi, non-vertebrates, e.g. insects, and vertebrates, e.g. mammals and fish.
  • a particularly preferred chimeric gene of the present invention is formed by connecting the transit peptide from the small subunit (SSU) of ribulose 1,5- bisphosphate carboxylase with a mutated aroA gene capable of imparting resistance to glyphosate.
  • SSU small subunit
  • Van den Broeck et al. Nature (1985) 313;358-363 describes a chimeric gene in which the small subunit gene is joined to the NPT-II gene (encoding bacterial neomycin phosphotransferase II).
  • the fusion protein encoded in both plasmids described in the paper consists of the 57-amino-acid transit peptide and the first methionine of a mature small subunit polypeptide, a 7-amino-acid linker fragment, and NPT-II lacking the first methionine.
  • this particular fusion product was capable of transferring the NPT- II gene into chloroplasts.
  • a functional mutant may be employed In which one or more, preferably one to three, amino acids have been replaced by other amino acids, preferably conservatively, to link the transit peptide gene to the aroA gene.
  • the chimeric gene may be prepared having its own initiation codon and stop codons, so that expression will be initiated and terminated at the appropriate codons.
  • a transcriptional initiation region including the RNA polymerase binding site and transcription initiation site, and terminator region will be provided 5' and 3' to the chimeric gene, respectively.
  • the transcription initiation region may be the native promoter region associated with the transit peptide.
  • the native transit peptide transcription initiation region may not be acceptable because it does not provide for the desired degree of transcription or constitutive transcription is desired, where the leader peptide transcription is inducible, or vice versa. Therefore, the native transcription initiation region may be substituted by a different region or the region upstream from the RNA polymerase binding site and transcription initiation may be substituted to provide for inducible transcription.
  • the transcription initiation regions which may be employed may be derived from various plant gene promoter regions, including such plant genes as small subunit (SSU) carboxylase, acyl carrier protein (ACP) and Elongation Factor 1, or may be bacterial plasmid gene promoters which are functional in plants, such as the opine synthase promoters of the Ti- or Ri-plasmids of Agrobacterium or viral promoters.
  • These promoters include the promoters associated with opine synthesis, e.g., octopine synthase, nopaline synthase, mannopine synthase, agropine synthase, etc.
  • Viral promoters include the cauliflower mosaic virus 35S promoter and region VI promoter.
  • an expression cassette can be developed where the chimeric gene is flanked by transcriptional initiation and termination regions to provide for the desired transcriptional regulation.
  • expression constructs are developed, where the transcriptional initiation and termination regulatory regions are provided separated by a polylinker having a plurality of restriction sites, where by insertion of or substitution of a small fragment of the linker with the chimeric gene, the chimeric gene may be ligated so as to be under the regulatory control of the expression cassette.
  • the expression cassette is normally carried on a vector capable of replication and selection in one or more hosts, particularly including prokaryotic hosts.
  • the expression cassette may be initially joined to other DNA regulatory regions.
  • the expression cassette will be joined to a replication system functional in prokaryotes, particularly E. coli, so as to allow for cloning of the expression cassette for isolation, sequencing, analysis, and the like.
  • Included with the replication system will usually be one or more markers which may allow for selection in the host, the markers usually involving biocide resistance, e.g., antibiotic resistance; heavy metal resistance; toxin resistance; complementation; providing prototrophy to an auxotrophic host; immunity; etc.
  • a marker will usually be desirable which allows for selection of those cells in which the injected DNA has become integrated and functional. Thus, markers will be selected whi ch can be detected in a plant hos t .
  • a tumor-inducing plasmid such as a Ti- or Ri-plasmid, which may be armed (causing gall formation) or disarmed (not causing gall formation). See Hoekema, Nature (1983) 303:179-180; EPA No. 116718 and W0 86/03776.
  • Various constructions can be prepared involving T-DNA where the expression cassette of interest may have a single T-DNA border, the right border, or be bordered on both the right and left sides by T-DNA borders. The borders will involve at least about 50bp of the T-DNA, usually at least about 100bp.
  • T-DNA structural genes with their expression systems may be included, so that integrating into a plant host will result in expression of an opine, which may be used as a marker for the presence of T-DNA integration.
  • an opine which may be used as a marker for the presence of T-DNA integration.
  • the particular manner in which the expression cassette is introduced into the nucleus of the host i3 not critical to this invention, so long as the expression cassette is present and capable of functioning to provide the desired product.
  • the expression cassette included in a prokaryotic vector having one or both T-DNA borders may be transformed into A. tumefaciens or A. rhizogenes containing a Ti- or Ri-plasmid respectively, for example, by the technique described by Zamoryski, e t al., in Genetic Engineering, Principles and Methods, Vol. 6 (eds. Setlow and Hollaender) 253-278 (Plenum, N.Y., 1984); Binary Vector application Serial No. 834,161; and A. Hoekeraa, The Binary Plant Vector System (1935), (Offsetdrukkerij Kanters, B.V. Alblessardum).
  • the expression cassette becomes integrated into the tumorinducing plasmid in the T-DNA, and the bacteria containing the cassette may then be used for infecting plant cells or tissue.
  • RNA which codes for the fused peptide.
  • the presence of expression can be detected in a variety of ways. Where the expression product provides a detectable phenotype, such as a novel phenotype or enhancement of an endogenous phenotype, the expression of the desired product may be determined by detecting the phenotype. Where a detectable phenotype is not available, antibodies specific for the mature product may be employed.
  • the chloroplasts may be isolated in accordance with conventional ways, disrupted and the Western or other technique employed for identifying the presence of the desired product.
  • the cell tissue e.g., protoplasts, explants, or cotyledons
  • the regeneration media will usually contain a bacterioide, e.g., carbenicillin (500mg/L), and may contain a selective reagent for selecting transformed cells.
  • a bacterioide e.g., carbenicillin (500mg/L)
  • kanamycin resistance gene APH3'II
  • kanamycin will be added to at least about 30mg/L and usually not more than about 500mg/L, preferably from about 50 to 100mg/L, in the selective medium.
  • the regeneration medium includes an appropriate salt source, such as Murashiga-Skoog salts medium, a carbon source, e.g., sucrose, with appropriate other additives, such as hormones, e.g., zeatin, etc., at about 0.75-2.25mg/L, myolnositol at about 50-200mg/L, etc.
  • a vitamin supplement may be added, e.g., Nitsch vitamins, at about 0.5 to 1.5ml/L of 1000x stock (usually 1.0ml/L), as is conventional in regeneration media.
  • the 1000x stock of Nitsch vitamins contains in a 100ml final volume: 50mg thlamine HCl, 200mg glycine, 50mg nicotinic acid, 50mg pyridoxine HCl, 50mg folic acid, 5ml biotin and water to volume.
  • the carbon source will be present in from 10 to 30g/L.
  • the regeneration medium contains about 0.5 to 1.0% agar, with the regeneration medium being buffered at about pH 6 ⁇ 0.5.
  • shoots normally develop. When the shoots are approximately 1 to 2 cm, they are excised at the base and transferred to a rooting medium, which may be the same medium on which the seedlings were grown, with carbenicillin and kanamycin sulfate added. Once the modified plants have been obtained, they can be grown to sufficient maturity to provide sufficient material to determine whether the desired product is still being produced in all or a portion of the plant cells. After expression of the desired product has been demonstrated in the plant, the plants may be bred to seed, used for crossing with other plants, as appropriate, to produce hybrids having the desired expression capability of the expression cassette or, as appropriate, produce various propagules for further propagation.
  • the chloroplasts are extremely important cell organelles. Therefore, delivery of proteins to the chioroplasts may allow for the engineering of herbicide resistance, alteration of amino acid metabolism, alteration of photosynthesis, fatty acid metabolism, and other important metabolic functions.
  • the leader peptide from this gene may be joined to an aroA gene, particularly an aroA gene expressing an enzyme resistant to inhibition by an enzyme inhibitor for the wild-type enzyme, as is described above.
  • transcriptional regulation systems such as those associated with T-DNA, e.g., octopine, nopaline, mannopine or agropine synthases, or the small subunit transcriptional regulation system.
  • the construction will Involve the terminator region of the leader peptide or transcription initiation region, which can be introduced downstream from the structural gene by any convenient means.
  • the terminator region will be from about 50bp to not more than about 1000bp from the stop codon(s).
  • the subject procedure results in the production of novel proteins. From one to 20 amino acids of the N-terminus of the mature product may be substituted by the polar region or the N-terminus extended by the polar region.
  • these proteins are distinguished by having an unnatural N-terminus coded for by the hydrophilic region.
  • an aroA gene comprising at its N-terminus from 3 to 20 heterologous amino acids.
  • the protein With the SSU subunit, the protein will comprise 14 to 18, preferably 16 amino acids of the mature SSU protein.
  • other of the chloroplast endogenous proteins may be similarly characterized by lacking their N-termini, either as a result of replacement of the natural N-termini with the polar region or by being fused to the polar region to provide an extension of the wild-type N-terminus.
  • pSRS2.1 is a genomic soybean clone (Berry-Lowe et al. (1982) supra).
  • TSSU3-8 and SSU3-2 are genomic tobacco clones (O'Neal et al. Nucl. Acid. Res. (1987) in press).
  • pSS15 is a pea cDNA clone (Coruzzi et al . , J . Biol . Chem . ( 1 983 ) 258:1399).
  • the transit peptide regions of the soybean and tobacco SSU are 75% homologous. The first was used for in vitro uptake studies, the latter for in vivo plant expression.
  • PUC12 (Cm R ) and pUC13 (Cm R ) were each digested with EcoRI and Hindlll and polylinkers from pUC18 and pUC19 were inserted respectively into the linearized pUC12 and puC13 to give pCGN565 and pCGN566 respectively.
  • Each of the plasmids carry a chloramphenicol resistance marker.
  • Plasmids Containing the Amino Terminal Portion of RUBPCssu (ribulose-1,5-blsphosphate carboxylase small subunit)
  • pSRS2.1 (Berry-Lowe et al., supra) contain i ng an EcoRl fragment which includes 5'-untranslated region and the 5'-coding region of RUBPCssu was digested with EcoRI to provide the fragment and the EcoRl f ragment inserted into the EcoRI site of pCGN565 and pCGN566, respectively, to provide pCGN330 and pCGM331, respectively.
  • pCGN331 was then further digested with Hindlll which removes most of the 5'-untranslated region to provide the amino terminal portion of the RUBPCssu gene carried on a Hindlll-EcoRI fragment.
  • PPMG11 (Comai e t al., Science (1983) 221 :370) contains a mutated aroA gene resistant to glyphosate Inhibition as a Sall-Hindlll fragment.
  • pPMG11 was digested with Sall and Bglll and inserted into BamHI- Sall digested pACYCl84 (Chang and Cohen, J. Bacteriol. (1978) 134:1141) to provide pPMG17, with the aroA fragment.
  • pUC9 (Vieira and Messing, Molecular Cloning (1982) Cold Spring Harbor Lab Manual) was partially digested with AccI and pPMG17 partially digested with Hpall to provide an about 1.6kbp fragment which was inserted into the AccI site of pUC9 to provide pPMG31.
  • pPMG31 was digested with Hindlll, resected about 150bp with Bal31, BamHI linkers ligated to the linear DNA and the DNA digested with BamHI and Sall. The resulting fragment carried the aroA gene with 8bp of the 5'-untranslated region (TGAGTTTC-sense strand).
  • M13-65B48 was digested with Narl and PstI, generating an aroA fragment lacking the DNA region 5' of the Narl site, corresponding to the amino terminal protion of the gene.
  • This fragment was cloned in pUC8 cut with AccI and PstI, resulting in pPMG53.
  • This plasmid encodes a lac-aroA fusion protein in which 11 amino acids of the pUC8 lac alpha gene replace the 14 amino acids of the N-tarminus of the aroA gene.
  • pPMG34 has been described previously (Stalker et al., J. Biol. Chem. (1985) 260:4724-4723).
  • the BamHI to Sall fragment containing the aroA gene was cloned in pUC9, resulting In pPMG34.1.
  • the 5'-untranslated region of the aroA gene was recessed by treatments with T4 DNA polymerase in the presence of a single nucleoside triphosphate, followed by mung bean nuclease digestion. After each T4 DNA Polymerase and mung bean treatment, the fragment was subcloned as a blunt to Sall insert Into a pUC vector, and transformants were screened for the expected product.
  • M13-65343 was digested with BamHI and Sall and the resulting BamHI-SalI fragment inserted into the BamHI-Sall site of pCGN565.
  • the resulting plasmid, pPMG63 was first linearized with Xmal, followed by digestion with mung bean nuclease to remove the overhangs, and the resulting fragment ligated to SphI linkers, followed by digestion with SphI and Sall.
  • PCGN566 was completely digested at the unique SphI and Sall sites and the Sphl-Sall fragment containing the aroA gene inserted into the site to provide pPMG54 which contains the chloramphenicol resistance gene.
  • pPMG64 was digested with SphI and a 0.6kb pCGN330 SphI fragment inserted into the SphI site so as to provide the RUBPCssu leader peptide In the proper orientation with the aroA gene.
  • the SphI site is proximal to the 3'-terminus of exon 1 of the RUBPCssu gene.
  • the SphI and BamHI sequences are separated by a single base pair and provide for the RUBPCssu leader peptide and processing signal in proper reading frame with the aroA gene. The sequence is as follows:
  • Plasmid pPMG72 was digested with Hindlll to remove the upstream untranslated (UT) region of the small subunit to provide plasmid pPMG72.
  • Plasmid pPMG72 was treated with Hindlll and EcoRI, and the SSU-aroA promoter/gene fragment was cloned in pSP64 (Meltonet al., Nucleic Acid Research (1986) 12:7035) which had been digested with Hindlll and EcoRI providing plasmid PCGN1068.
  • the vector pSP64 allows in vitro transcription of cloned DNA. Construction of SSU-aroA Fusion 3
  • Plasmid ⁇ CGN1068 was cut with Xbal, the resulting stoppered ends were "filled” with the large EcoRI DNA polymerase fragment (Klenow fragment), the plasmid was cut again with Smal and ligated. This caused the loss of a BamHI site present between the
  • the resulting plasmid pCGN1075 was cut with EcoRI and Hindlll releasing the SSU-aroA chimeric gene (Fusion 1). This gene was cloned in Bluescribe-M13 vector (Vector Cloning Systems, San Diego) cut with EcoRI and Hindlll resulting in
  • PCGN1076 Plasmid pCGN1076 was cut with SphI and BamHI and a 70bp SphI-Seu3A fragment from a pea SSU cDNA clone was ligated to pCGN1076 resulting in pCGN1077.
  • Such 70bp SphI-Seu3A fragment was isolated by digesting plasmid pSS15 (G. Coruzzi et a l ., J. Biol. Chem. (1983) 258:1399) with Seu3A and SphI, separating the resulting fragments by agarose gel electrophoresis and electroelution from the gel.
  • the chimeric gene in pCGN1077 consisted of the transit peptide of the soybean SSU, part of the mature pea SSU (24 amino acids) and the aroA gene. It was called Fusion 3. By digestion of PCGN1077 with EcoRI and Hindlll and subsequent ligation of the chimeric gene to pSP64 (D.A. Melton et al., Nucleic Acid Research (1984) 12:7035) cut with Hindlll and EcoRI, plasmi d pCGN1036 was constructed. The chimeric SSU-aroA gene in pCGN1086 can be transcribed in vitro by the use of SPG-DNA polymerase.
  • a control plasmid containing aroA only was constructed by digesting pPMG63 with BamHI and Sall and cloning it in pSP64 treated with BamHI and Sall, resulting in pCGN1008 Construction of SSU-aroA Fusion 4
  • the aroA gene of ⁇ PMG34.3 was excised as a BamHI to Sall fragment and gel purified.
  • Plasmid pPMG72 was digested with BamHI to Sall. The fragment containing the vector and the SSU coding region was gel purified and ligated to the previously purified aroA gene. The resulting plasmid contained an SSU-aroA fusion lacking the start Met codon of aroA.
  • PCGN1008, pCGN1068, and pCGN1086 were linearized with EcoRI. They were then transcribed by the addition of SP5-RNA polymerase and nucleotide precursors according to the manufacturer specifications (Promego-Biotec, Madison, Wisconsin). The RNA was then added to in vitro translation extracts from wheat germ (BRL, Bethesda, MD) and translated in the presence of s 35 -methionine (New England Nuclear). The resulting peptides were analyzed by SDS-polyacrylaraide gel electrophoresis. Translation of mRNA from pCGN1008 resulted in the synthesis of a 43kd peptide corresponding in mobility to wild-type aroA product.
  • pCGN1096 To generate a large number of fusions by the use of nuclease Bal31 resection a specialized vector wa3 constructed called pCGN1096.
  • the resulting plasmid, pCGN!094 codes for an hybrid SSU having the transit peptide of the soybean clone, and the mature portion of the pea clone and carries SstI and EcoRI sites 3' of the coding region.
  • Plasmid pPMG34.3 ws digested with Sall, the site filled in as above and EcoRI linkers were ligated into the site resulting in plasmid pCGN1092.
  • the latter plasmid was digested with SstI and Smal and into it was ligated the kanamycin resistance gene excised from pCGN1093 with SstI and Smal giving pCGN1095.
  • the kanamycin and aroA gene were excised as a piece from pCGN1095 by digestion with SstI and EcoRI and Inserted Into the SstI and EcoRI sites of pCGN 1094 giving pCGN1096.
  • pCGN1096 contains 5' to 3' the following pertinent features: The SSU gene - a polylinker coding for PstI, Sall, SstI, and Kpnl - the kanamycin resistance gene - Smal and BamHI restrition sites - the aroA gene without the original ATG start codon. Generation of SSU-aroA fusions with pCGN1096
  • Plasmid PCGN1096 was cut at the Sail site and digested with endonuclease Bal31 for different lengths of time. The resected plasmid was then digested with Smal and religated. Treatment with Bal31 deleted different amounts of SSU coding region starting from the 3' end of the gene. It also deleted different portions of the kanamycin resistance gene starting from the 5' end of the gene. Digestion with Smal deleted the remainder of the kanamycin resistance gene and ligation joined the ATG-less aroA gene to a point within the SSU coding region. One fusion out of three should generate a translationally active fusion between the SSU coding region and aroA. These events were selected by transforming the resulting plasmids in E.
  • coli LC3 an aroA mutant (Coraai et al., (1983) supra), and selecting for the plasmid by ampicillin resistance and for translationally correct fusions by growth on minimal medium. Complementing plasmids were isolated and characterized by restriction digestion. The sequence of the fusion was determined by Sanger dideoxy sequence analysis using a primer homologous to the amino terminal region of aroA.
  • pCGNISOL contains a cDNA of spinach ACP-I (Scherer and Knauf, Plant Mol. Bio. (1987) 9: 127-134).
  • the ACP gene was excised from pCGNISOL with Ncol and EcoRI, the Ncol end was filled in with the Klenow fragment of DNA Poll, and cloned into PUC18 cut with Smal and EcoRI to give PCGN1919.
  • the acp carrying plasmid pCGN191919 was digested with EcoRI and into that site was cloned the kanamycin aroA coding region of PCGN1095, resulting in pCGN1608.
  • Plasmid pCGN1608 was cut at the SstI site and digested with endonuclease Bal31 for different lengths of time. The resected plasmid was then digested with Smal and religated. Treatment with Bal31 deleted different amounts of acp coding region starting from the 3' end of the gene. It also deleted different portions of the kanamycin resistance gene starting from the 5' end of the gene. Digestion with Smal deleted the remainder of the kanamycin resistance gene and ligation joined the ATG-less aroA gene to a point within the acp coding region. One fusion out of three should generate a translationally active fusion between the acp coding region and aroA.
  • fusions chosen for characterization were cloned into an expression vector as follows. Fusions originating from pCGN1608 were cloned as Sall to EcoRI fragments Into pCGN1906 cut with the same enzymes.
  • pCGN1906 is an expression vector having the CoMV35S promoter (nucleotides 7146 to 7546) and the OCS 3' region (12,823 to 11,207) (Barker et al., Plant Mol. Bio. (1983) 2:335) cloned via linkers into pUC backbone. Sail and EcoRI sites are located between the 5' promoter and 3' termination region allowing proper positioning of the gene to be expressed. The resulting plasmids contained the fusion under the control of the CaMV 35S promoter and spliced to the tml polyadenylation signal. Fusions originating from
  • PCGN1608 were cloned as BamHI to EcoRI fragments into the expression vector pCGN1096, cut with Bglll and EcoRI. The later carries the CaMV 35S promoter and the ocs 3' polyadenylation region separated by Bglll, SaIl and EcoRI sites. The resulting plasmids were characterized by restriction endonuclease digestion, purified and electroporated into Nicotlana tobacum protoplasts. After 48 hours incubation the electroporated protoplasts were analyzed for the presence of aroA related proteins by Western blot analysis (Comai et al. (1985) supra).
  • Fusions 1 and 3 incorporate respectively the first 1 and 24 amino acids of the mature SSU. Fusion 4 differs from fusion 3 in the linker-coded region and in the deletion of the aroA start codon.
  • the fusion genes in the SP6 transcription vector pSP64 (Melton et al., Nucl. Acids. Res. (1984) 12:7035-7056) were cloned and then transcribed and translated in vitro. Translation of mRNA from pCGN1008 resulted in the synthesis of a 43 kDa peptide corresponding in mobility to wild-type aroA product. Translation of mRNA from pCGN1068 and pCGN1086 resulted in peptides of respectively 50 and 53 kDa. Radiolabelled precursor was then incubated with isolated spinach chloroplasts.
  • Fusion 1 protein is not efficiently translocated into the chloroplasts, as negligible amounts are found in either the membrane or stromatic fraction.
  • Fusion 3 is translocated: two polypeptides are found in the stromatic fraction and have MW of 47 and 46 kDa, the expected size for the processed product, A change in mobility of the translocated proteins is visible after trypsin treatment. This could indicate that the transport is not complete and part of the protein is still accessible to the protease. In support of this, small amounts of the 47 kDa species of EPSP synthase are present in the membrane fraction.
  • Partial digestion upon trypsin treatment of the chloroplasts could also be explained by limited access to the stroma by trypsun.
  • the 47 kDa species could be the result of an incomplete transport process and, therefore, be partially exposed to proteolysis.
  • Fusions incorporating 12, 16, 19, 34. 64 and 92 amino acids of the mature small subunit were isolated and characterized. To facilitate the analysis of delivery these fusions were cloned In an expression vector and electroporated into leaf protoplasts. After 48 hours, the protoplasts were analyzed by Western blot using anti aroA antiserum. Although chloroplasts were not isolated, Western blot unequivocally established that the protein was properly delivered and processed since the difference in size between the precursor and the mature protein is about 7 kDa. In no experiment was a precursor ever detected.
  • a construct incorporating 35 amino acids of the mature ACP was successfully delivered into the chloroplast although at relatively low efficiency.
  • a second fusion incorporating 42 amino acids was not delivered at all.
  • the pattern of use of ACP as a transit peptide is based on only two fusions, it resembles the one of the small subunit.
  • a peptide region at the amino terminus of the mature protein that has been delivered is needed for optimal efficiency. This peptide has salient characteristics; both in the SSU and in the acp it is predicted by the analysis of Kyte and Doollttle, J. Mol. Biol. (1982) 157:105) to be located on the surface of the protein.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Auxiliary Devices For And Details Of Packaging Control (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

De nouvelles constructions chimériques sont destinées à l'expression de gènes chimériques ayant un peptide de transit à terminaison N pour effectuer une translation efficace du cytoplasme vers le chloroplaste et un gène étranger capable de fonctionner en association avec le chloroplaste. En particulier, le peptide de transit d'une petite sous-unité de ribulose-1,5-biphosphate carboxylase est joint à un gène aroA exprimant un enzyme résistant aux inhibiteurs avec conservation du signal de traitement pour obtenir le produit d'expression aroA mature dans le chloroplaste.
EP19870906870 1986-09-26 1987-09-22 Apport intracellulaire de produits d'expression. Withdrawn EP0285646A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91240886A 1986-09-26 1986-09-26
US912408 1986-09-26

Publications (2)

Publication Number Publication Date
EP0285646A1 EP0285646A1 (fr) 1988-10-12
EP0285646A4 true EP0285646A4 (fr) 1989-12-18

Family

ID=25431868

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870906870 Withdrawn EP0285646A4 (fr) 1986-09-26 1987-09-22 Apport intracellulaire de produits d'expression.

Country Status (4)

Country Link
EP (1) EP0285646A4 (fr)
JP (1) JPH01501038A (fr)
AU (1) AU620317B2 (fr)
WO (1) WO1988002402A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538878A (en) * 1988-08-08 1996-07-23 Calgene, Inc. Superoxide dismutase expression in plants
WO1990002172A1 (fr) * 1988-08-18 1990-03-08 Calgene, Inc. Facteur d'elongation de plantes, promoteurs, sequences codantes et utilisations
AU644619B2 (en) * 1989-12-21 1993-12-16 Advanced Technologies (Cambridge) Limited Modification of plant metabolism
EP0536293B1 (fr) * 1990-06-18 2002-01-30 Monsanto Technology LLC Plantes a teneur en amidon augmentee
USRE36449E (en) * 1991-03-05 1999-12-14 Rhone-Poulenc Agro Chimeric gene for the transformation of plants
FR2673643B1 (fr) * 1991-03-05 1993-05-21 Rhone Poulenc Agrochimie Peptide de transit pour l'insertion d'un gene etranger dans un gene vegetal et plantes transformees en utilisant ce peptide.
WO1998010074A2 (fr) * 1996-09-04 1998-03-12 Basf Aktiengesellschaft Adenylosuccinate-synthetase
DE10014412A1 (de) * 2000-03-24 2001-10-04 Mpb Cologne Gmbh Molecular Pla Expressionsvektoren zur Anreicherung eines rekombinant hergestellten Proteins in unterschiedlichen Zellkompartimenten
US7105718B2 (en) 2000-03-31 2006-09-12 The Regents Of The University Of Colorado Compositions and methods for regulating metabolism in plants
WO2001075131A2 (fr) * 2000-03-31 2001-10-11 University Technology Corporation Compositions et procedes permettant de reguler le metabolisme de vegetaux
FR2841247B1 (fr) * 2002-06-21 2004-10-22 Genoplante Valor Peptide d'adressage plastidial
FR2961375B1 (fr) 2010-06-16 2016-05-13 Inst De Rech Pour Le Dev (Ird) Surproduction d'acide jasmonique dans des plantes transgeniques
FR2984076A1 (fr) 2011-12-15 2013-06-21 Inst Rech Developpement Ird Surproduction de jasmonates dans des plantes transgeniques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189707A2 (fr) * 1984-12-28 1986-08-06 Plant Genetic Systems N.V. DNA recombinant qui peut être introduit dans des cellules de plantes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189707A2 (fr) * 1984-12-28 1986-08-06 Plant Genetic Systems N.V. DNA recombinant qui peut être introduit dans des cellules de plantes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
SCIENCE, vol. 233, 25th July 1986, pages 478-481; D.M. SHAH et al.: "Engineering herbicide tolerance in transgenic plants" *
See also references of WO8802402A1 *
THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 263, no. 29, 15th October 1988, pages 15104-15109, The American Society for Biochemistry and Molecular Biology, US; L. COMAI et al.: "Chloroplast transport of a ribulose bisphosphate carboxylase small subunit-5-enolpyruvyl 3-phosphoshikimate synthase chimeric protein requires part of the mature small subunit in addition to the transit peptide" *
TIBTECH, vol. 5, no. 2, February 1987, & 7TH INTERNATIONAL SYMPOSIUM ON THE STRUCTURE AND FUNCTION OF PLANT LIPIDS, University of California, Davis, California, US, 27th July - 1st August 1986, pages 40-47, Elsevier Science Publishers, B.V., Amsterdam, NL; V.C. KNAUF: "The application of genetic engineering to oilseed crops" *
WORLD BIOTECH: REPORT, vol. 2, 1985, pages 97-108; B.J. MAZUR et al.: "Cloning herbicide resistance genes into and out of plants" *

Also Published As

Publication number Publication date
JPH01501038A (ja) 1989-04-13
EP0285646A1 (fr) 1988-10-12
WO1988002402A1 (fr) 1988-04-07
AU8079787A (en) 1988-04-21
AU620317B2 (en) 1992-02-20

Similar Documents

Publication Publication Date Title
US5215912A (en) Monocot seed storage proteins in dicots
US5003045A (en) Modified 7S legume seed storage proteins
CA2061636C (fr) Gene chimerique pour la transformation de plantes
Tabe et al. A biotechnological approach to improving the nutritive value of alfalfa
US8981188B2 (en) Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase
CA1313830C (fr) Plantes resistant au glyphosate
CA2073412A1 (fr) Plants transgeniques exempts de genes de selection
US8563687B2 (en) Synthetic genes for plant gums and other hydroxyproline rich glycoproteins
AU620317B2 (en) Intracellular directed delivery of expression products
JP2000503858A (ja) エディティングに基づいて選択可能なプラスチドマーカー遺伝子
US5767362A (en) Methods and compositions for modulating lipid content of plant tissues
EP1144665A1 (fr) Methodes de transformation de plastes
US7238854B2 (en) Method of controlling site-specific recombination
CN105061569A (zh) 一种与植物抗逆性相关的SiMYB107蛋白及其相关生物材料与应用
US20230313212A1 (en) Plastid transformation by complementation of nuclear mutations
EP0240331B1 (fr) Plantes résistant aux virus contenant une protéine de l'enveloppe d'un virus
US6570062B1 (en) Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
Jang et al. Chloroplast targeting signal of a rice rbcS gene enhances transgene expression
US6617494B2 (en) Methods for identifying transgenic plants using morphological markers
US20040117874A1 (en) Methods for accumulating translocated proteins
KR100927803B1 (ko) 식물 형질전환체를 선별하기 위한 마커로서 ｇｐｔ 유전자
CN116970048A (zh) 水稻育性基因OsRIP1以及应用
Yamauchi Brazil nut 2S albumin was synthesized in a transgenic French bean seed with a promoter of the gene for canavalin, 7S globulin from Canavalia gladiata
US20050268351A1 (en) Modulation of storage organs
US20050081266A1 (en) Modulation of storage organs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880616

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: STALKER, DAVID, M.

Inventor name: COMAI, LUCA

Inventor name: KNAUF, VIC, CHARLES

A4 Supplementary search report drawn up and despatched

Effective date: 19891218

17Q First examination report despatched

Effective date: 19910920

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19920925